Drooid Logo
Back to today’s briefing

Story perspectives

Stocks Surge: Telomir Rises 31%, Galecto Soars 662%

10/8/2025

50 5 Full Breakdown

1 of 2

Story summary
  • Telomir Pharmaceuticals' shares surged 31% to $1.86 after preclinical results for Telomir-1 in prostate cancer models.
  • Galecto Inc. stock rose 662.51% to $28.38 on speculative trading.
  • U.S. stocks rose, with the Dow Jones Industrial Average up over 100 points.
  • McCormick & Co. posted earnings of 85 cents per share, above estimates.
  • Redbook retail sales index rose 5.8% YoY for week ending October 4.
1 / 2